Investors are suing UnitedHealth Group, alleging the company misled them by failing to disclose information on how the company was being affected by the backlash over its response to the December killing of CEO Brian Thompson.
Investor Roberto Faller filed a proposed class action lawsuit in the Southern District of New York on Wednesday, alleging that UnitedHealth inflated its stock price by projecting earnings per share of $29.50 to $30 in December. The suit claims the company reaffirmed this forecast in January, despite internal struggles and growing public backlash over its high rate of claim denials and Thompson’s death.